| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000008551 |
| Receipt No. | R000010051 |
| Official scientific title of the study | A study on relapse of the symptom comparing 2 weeks and 8 weeks of treatment period in GERD patients using the newly established GerdQ questionnaires |
| Date of disclosure of the study information | 2012/07/30 |
| Last modified on | 2016/07/30 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A study on relapse of the symptom comparing 2 weeks and 8 weeks of treatment period in GERD patients using the newly established GerdQ questionnaires | |
| Title of the study (Brief title) | GERD treatment period study | |
| Region |
|
|
| Condition | ||
| Condition | GERD | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the relapse of GER symptoms in relation with the length of the treatment in the patients with reflux esophagitis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | length of the GER symptom free periods after the treatment |
| Key secondary outcomes | 1) factors affecting the relapse of GERD
2) difference of GER symptoms between before and after the 2 week treatment and the rates of the disappearance of GER symptoms 3) the severity of GER symptoms in case of the relapse |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | no additional treatment | |
| Interventions/Control_2 | Additional treatment of esomeprazole for 6 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | LA grade A or B diagnosed by esophagoscopy within 6 months
Having GER symptoms Disappearance of GER symptoms after the treatment by esomeprazole (20 mg/day for 2 weeks) by GerdQ questionnaire |
|||
| Key exclusion criteria | Patiets with the history of gastric surgeries
Patients with alarm symptoms such as vomiting, GI bleeding, rapid body weight loss Patients of alcohol or drug dependence Patients with severe endocrine problems Patients with severe injuries of heart, liver, kidney or bone marrow functions Patients with allergy against the test drugs Patients with pregnancy, possible pregnancy or breast feeding, or hope of pregnancy during the test period Patients whom the doctor decide as not proper for the study |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Masashi Matsushima |
| Organization | Tokai University Tokyo Hospital |
| Division name | Internal Medicine (Gastroenterology) |
| Address | 1-2-5 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan |
| TEL | 03-3370-2321 |
| Public contact | |
| Name of contact person | Masashi Matsushima |
| Organization | Tokai University Tokyo Hospital |
| Division name | Internal Medicine (Gastroenterology) |
| Address | 1-2-5 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan |
| TEL | 03-3370-2321 |
| Homepage URL | |
| Sponsor | |
| Institute | Tokai University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Showa University Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東海大学東京病院(東京都) Tokai University Tokyo Hospital
東海大学医学部付属病院(神奈川県) Tokai University Hospital 昭和大学病院(東京都)Showa University Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010051 |